ARCHIVES

Diet Supplements Should Be Held To Scientific Standards, Broder Tells House

This article is from The Cancer Letter archive.

Vol. 19 No. 32 | August 6, 1993

Download PDF Visit The Full Archive

Related Articles

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

November 9, 2007

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

Program Announcement listed.

July 25, 2003

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

October 31, 2003

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014